Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 7/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.56 |
| ▸ | PARP1 | P09874 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.49 |
| ▸ | STAT3 | P40763 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12301161 | 0.93 | MAPT (0.53) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL15004125 | 0.93 | MAPT (0.53) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL12248436 | 0.93 | GCK (0.54) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL12300934 | 0.93 | MAPT (0.63) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL14992571 | 0.92 | PARP1 (0.60) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL12300952 | 0.91 | MAPT (0.66) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL16523127 | 0.91 | MAPT (0.52) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL12249093 | 0.91 | GCK (0.56) | MAPTALDH1A1THRBMAPK1MEN1 | |
| SCHEMBL12249080 | 0.91 | PARP1 (0.61) | MAPTALDH1A1THRBMAPK1TSHR | |
| SCHEMBL12300955 | 0.90 | MAPT (0.51) | MAPTALDH1A1THRBMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120123621-A | Reservoir water temperature estimation method, system and storage medium | 国能大渡河瀑布沟发电有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-116109571-B | Automatic fiber bundle reconstruction method and system for facial auditory nerve | 浙江大学 | 2024-04-26 | — | — | CN | claimed |
| CN-114285055-B | Intelligent power supply management method combining wind-solar power generation | 金名正元（北京）科技有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-114421558-A | Intelligent power supply management method | 金名正元（北京）科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-114285055-A | Intelligent power supply management method combining wind-solar power generation | 金名正元（北京）科技有限公司 | 2022-04-05 | — | — | CN | claimed |
| EP-2783217-B1 | BIOMARKERS FOR CANCERS RESPONSIVE TO MODULATORS OF HEC1 ACTIVITY | TAIVEX THERAPEUTICS CORP (TW) | 2019-04-24 | — | — | EP | claimed |
| US-9976183-B2 | Biomarkers for cancers responsive to modulators of HEC1 activity | TAIVEX THERAPEUTICS CORPORATION (TW) | 2018-05-22 | — | — | US | claimed |
| EP-2783217-A1 | BIOMARKERS FOR CANCERS RESPONSIVE TO MODULATORS OF HEC1 ACTIVITY | Taivex Therapeutics Corporation (TW) | 2014-10-01 | — | — | EP | claimed |
| US-20130171634-A1 | BIOMARKERS FOR CANCERS RESPONSIVE TO MODULATORS OF HEC1 ACTIVITY | TAIVEX THERAPEUTICS CORPORATION (TW) | 2013-07-04 | — | — | US | claimed |
| WO-2013078145-A1 | BIOMARKERS FOR CANCERS RESPONSIVE TO MODULATORS OF HEC1 ACTIVITY | TAIVEX THERAPEUTICS CORPORATION (TW) | 2013-05-30 | — | — | WO | claimed |
| US-12641132-B2 | Methods and apparatuses for selecting a media resource function or a media gateway in an internet protocol session | TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) (SE) | 2026-05-26 | — | — | US | disclosed |
| EP-4744386-A1 | METHOD AND APPARATUS FOR HANDLING OF NETWORK SLICE SELECTION ASSISTANCE INFORMATION LISTS IN A WIRELESS COMMUNICATION SYSTEM | Samsung Electronics Co., Ltd. (KR) | 2026-05-20 | — | — | EP | disclosed |
| CN-119844892-B | Method and device for controlling rotating speed of variable frequency compressor of air conditioner | 青岛海尔智慧楼宇科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2026101177-A1 | HANDLING CELL SELECTION OR RESELECTION OF A CELL ASSOCIATED WITH A TAI IN A WIRELESS COMMUNICATION SYSTEM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-05-15 | — | — | WO | disclosed |
| US-12627951-B2 | Fifth generation core enhancements to support ad hoc and dynamic group based services for edge deployments | NOKIA TECHNOLOGIES OY (FI) | 2026-05-12 | — | — | US | disclosed |
| US-20130171634-A1 | BIOMARKERS FOR CANCERS RESPONSIVE TO MODULATORS OF HEC1 ACTIVITY | TAIVEX THERAPEUTICS CORPORATION (TW) | 2013-07-04 | — | — | US | disclosed |
| WO-2013082324-A1 | IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | TAIVEX THERAPEUTICS CORPORATION (TW) | 2013-06-06 | — | — | WO | disclosed |
| WO-2013082324-A1 | IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | TAIVEX THERAPEUTICS CORPORATION (TW) | 2013-06-06 | — | — | WO | disclosed |
| WO-2013078145-A1 | BIOMARKERS FOR CANCERS RESPONSIVE TO MODULATORS OF HEC1 ACTIVITY | TAIVEX THERAPEUTICS CORPORATION (TW) | 2013-05-30 | — | — | WO | disclosed |
| US-20110230486-A1 | Modulators Of HEC1 Activity And Methods Therefor | TAIVEX THERAPEUTICS CORPORATION (TW) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12627951-B2 | Fifth generation core enhancements to support ad hoc and dynamic group based services for edge deployments | HTR3E, NT5M, HTR5A | MAPT 153/4885ALDH1A1 1752/4885THRB 250/4885 |
| US-12641132-B2 | Methods and apparatuses for selecting a media resource function or a media gateway in an internet protocol session | SARAF, PLA2G2F, PRPF8 | MAPT 2538/4885ALDH1A1 4464/4885THRB 4031/4885 |
| US-20110230486-A1 | Modulators Of HEC1 Activity And Methods Therefor | WEE1, WEE2, NEK11 | MAPT 2820/4885ALDH1A1 3229/4885THRB 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.